CDK5 and cancer: Over the past years, a vast number of kinases have been reported to be strongly associated with cancer, positioning protein kinase inhibition as an emerging therapeutic strategy.[33, 34] Among these, CDK5 has been highlighted as a valuable target in cancer treatment.